Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer (RADAR II E)
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Budapest, Hungary
- Research Site
-
Komlo, Hungary
- Research Site
-
Miskolc, Hungary
- Research Site
-
Mohacs, Hungary
- Research Site
-
Vac, Hungary
- Research Site
-
Zalaegerszeg, Hungary
- Research Site
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Provision of informed consent
- Postmenopausal, hormon receptor positive patients with early breast cancer treated with Arimidex
- Investigators are requested to recruit patients only with at least 1 month prior Arimidex treatment.
Exclusion Criteria:
- Allergy to substance of medication
- Pre-perimenopausal woman
- Woman not eligible for treatment
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Elements of the investigator questionnaire SF RAND-36 questionnaire
Time Frame: Quarterly (plus or minus 3 days )
|
Quarterly (plus or minus 3 days )
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Investigator Assessment Report
Time Frame: Yearly (plus or minus 1 week )
|
Yearly (plus or minus 1 week )
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Zsolt Horváth, M.D., National Institute of Oncology
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- NIS-OHU-ARI-2007/1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.